Peak6 Investments LLC United Therapeutics Corp Put Options Transaction History

Peak6 Investments LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Aug 11, 2023	SELL	$205.19 - $232.99 $943,874 - $1.07 Million	-4,600 Reduced 82.14%	1,000 $220,000
Q1 2023 May 12, 2023	BUY	$212.99 - $276.17 $1.19 Million - $1.55 Million	5,600 New	5,600 $1.25 Million
Q2 2020 Aug 14, 2020	BUY	$92.74 - $125.82 $3.42 Million - $4.64 Million	36,900 Added 595.16%	43,100 $5.22 Million
Q1 2020 May 14, 2020	SELL	$79.39 - $115.35 $7.42 Million - $10.8 Million	-93,400 Reduced 93.78%	6,200 $588,000
Q3 2019 Nov 08, 2019	SELL	$74.85 - $85.99 $6.07 Million - $6.97 Million	-81,100 Reduced 44.88%	99,600 $7.94 Million
Q2 2019 Aug 14, 2019	BUY	$76.06 - $120.81 $6.87 Million - $10.9 Million	90,300 Added 99.89%	180,700 $14.1 Million
Q1 2019 May 15, 2019	BUY	$107.15 - $126.84 $9.69 Million - $11.5 Million	90,400 New	90,400 $10.6 Million

669

42.8M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $17B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.